ロード中...
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing
Antiplatelet therapy with P2Y(12) receptor inhibitors (clopidogrel, prasugrel, ticagrelor, cangrelor) is a cornerstone of medical therapy after percutaneous coronary interventions. Significant prevalence of high on-treatment platelet reactivity (HTPR) on clopidogrel treatment led to introduction of...
保存先:
| 出版年: | Front Cardiovasc Med |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901499/ https://ncbi.nlm.nih.gov/pubmed/31850373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00176 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|